CRISPR-Cas9-edited T cells could be used to boost the immune response against cancer. | McGovern Institute for Brain Research at MIT
https://www.aaas.org/news/phase-i-clinical-trial-gene-edited-cells-cancer-proves-safe-and-durable
CRISPR-Cas9-edited T cells could be used to boost the immune response against cancer. | McGovern Institute for Brain Research at MIT
https://www.aaas.org/news/phase-i-clinical-trial-gene-edited-cells-cancer-proves-safe-and-durable